Cardiac Myxoma is the most common benign intracardiac tumor of heart. We studied its incidence, clinical presentations, short term outcome, morbidity and mortality following surgery over a period of 17 years. The study was performed inthe department of cardiac surgery, National institute of Cadiovascular diseases (NICVD) Dhaka, over a period from 2000to 2016. NICVD is the tertiary hospital for cardiovascular surgery in the Government sector. Over this period of 17 years 11,923 open heart surgery was done of which 129 were cardiac myxoma patients. As a result, cardiac myxoma patients constituted 1.08%of all open heart surgery. Preoperative diagnosis was done on clinical presentations and 2D echocardiography, which is the most important tool for its diagnosis. Most of the patients presented at 4th to 5th decade of life. The patients presented with triad ofvalve obstructive features, embolic symptoms andconstitutional symptoms alone or in combination. Among all myxoma patients, majority(86.6%) had left atrial myxoma. Cardiac myxoma forms a very small percentage of all cardiac diseases requiring surgical treatment. Immediate surgical excision is indicated in all patients to avoid life-threatening complications. Outcome of surgical treatment was excellent.Bangladesh Heart Journal 2017; 32(2) : 85-88
e24813th International Congress on Infectious Diseases Abstracts, Poster Presentations ination and acid-fast staining, they had been cultured in Lewenstein-Jensen medium. After isolation of mycobacteria by differential tests such as niacin, nitrate reduction, arylsulfatase, catalase, urease, pyrazinamidase, susceptibility to TCH, tween hydrolysis, tellurite reduction, tollerance to 5% NaCl, rate of growth and pigmentation (dark-light), their antibiotic resistance and susceptibility were studied. Other bacteria were identified by staining and culturing in different media as standard methods.Results: Among 88 samples, 3 mycobacteria isolated (3.4%); out of these 3 proved agents cases. 1 M. chelonae (Rapidly growing) 2 cases M. scrofulaceum Antimycobacteria susceptibility test to INH, SM, RMP EMB, KM, THA were done. E. coli (41% 0 and S. Coagulase negative (38%) were isolated.Conclusion: Since atypical mycobacteria exist in soil, and some of cases from these bacteria have been isolated in Iran, therefore, isolation of them from person especially children after a disaster such as earthquake is important.
Background: Postoperative mediastinal bleeding in patients undergoing cardiac surgery is still one of the most common complications. Objective: This study was intended to investigate the efficacy of topical tranexamic acid in reducing postoperative bleeding after post-operative cardiovascular surgery. Methodology: In this non-randomized, double blinded, clinical trial, patients undergoing Off-Pump Coronary Artery Bypass (OPCAB) surgery in NICVD, Dhaka, Bangladesh during January 2014 to December 2015 and fulfilling inclusion and exclusion criteria were recruited. They were assigned in two groups- 30 patients in tranexamic acid group (Group 1) and 30 patients in placebo group (Group 2). On completion of the grafting, before closure of the sternum tranexamic acid (2.5 g/25 mL) or placebo (25 mL of saline) diluted in 100 mL of warm saline (370 C) was instilled into the pericardial cavity including the mediastinal tissues and left for 5 minutes. Then it was cleared out by wall sucker and sternum was closed. Results: There was no significant difference in baseline demographic data, basic clinical characteristics and preoperative coagulation profile between the 2 groups (P > 0.05). Total mediastinal bleeding in group 1 and group 2 patients were421.67±70.32 vs 593.33±77.38ml, p<0.001. In case of, whole blood transfusion in group 1 and group 2 patients were 0.87±0.0.73 units and1.77±0.57 units respectively, p<0.001. Conclusion: No patient required reoperation for bleeding and there was no incidence of prolonged ventilation, MI, thromboembolism, DVT or CVA in any of the patients in either group. Journal of National Institute of Neurosciences Bangladesh, July 2021, Vol. 7, No. 2, pp. 142-146
Hydatid cystic disease results from infection with the larval or adult form of the Echinococcus Granulosus(tapeworm). Cardiac involvement is seen in 0.5% to 2% of patients withhydatid disease and involvement of the right atrium(RA), main pulmonary artery(MPA) and right pulmonary artery(RPA) are very rare.In this case a 22-yr-old farmer woman from Raigong, Sirajgong, Bangladesh presented to the ShahidZiaur Rahman Medical College hospital, Bogra with the complaints of breathlessness for 10 months; haemoptysis and chest pain for last 3 months.CT scan of the chest showed cystic lesion on right hilar region with right sided pulmonary inflammatory lesion. CT guided FNAC revealed benign right bronchogenic cyst. Echocardiography showed right atrial(RA) thrombus. CT angiogram report showed complete occlusion of right pulmonary artery(RPA) with thrombus, main pulmonary artery(MPA) was partially occluded with thrombus &thrombus in right atrium(RA). Under cardiopulmonary bypass, a multiloculated mass was removed from RA and a cyst like structure removed from MPA and RPA. Histopathological report of the biopsy specimen revealed hydatid cyst and presence of EchinococcusAb confirmed the diagnosis of Hydatid disease.Bangladesh Heart Journal 2017; 32(2) : 125-129
Excess dilatation of the left atrium >60 mm is known in the literature as a gigantic atrium. This dilation is most commonly encountered in the mitral insufficiency of rheumatic etiology, but also in severe prolapses of the mitral valve, permanent atrial fibrillation, and at the leftright shunt with cardiac insufficiency. In this paper, we presented a case study of severe mitral stenosis with giant LA with LA thrombus in a 42 years old female patient. The patient underwent successful mitral valve replacement and removal of LA thrombus and discharged from the hospital with advice. Bangladesh Heart Journal 2018; 33(2) : 141-144
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.